Our vision
Delivering the Highest Quality Cannabis Products to Ensure Patient Safety
At Dopiopharm, our mission is to offer a broad range of premium-quality cannabis products sourced from first-class cultivation. We prioritize consistent quality and reliable delivery, ensuring our customers and patients receive only the best.

To achieve this vision, we sought a partner capable of providing vertical integration while allowing us to maintain our independence. With Tikun Olam Greece S.A., we have found the perfect match. Together, we are continuously raising our quality standards and optimizing our product offerings.

For the German market, we have established an exclusive partnership to deliver first-class cannabis products to our customers.
Tikun cannabis products by dopiopharm
Medical cannabis pioneer and innovator for cannabis products with scientific evidence
Pioneers and Innovators in Medical Cannabis with Scientific Evidence
Founded in Israel in 2005, Tikun Olam is a global leader in medical cannabis research and development. From the very beginning, the company has conducted groundbreaking Clinical Research in collaboration with leading scientists and universities. Notably, the “Erez” variety was the world’s first cannabis product to undergo Clinical studies .

Tikun Olam has compiled a comprehensive database of over 40,000 patient cases, providing valuable insights into the therapeutic applications of medical cannabis for conditions such as Parkinson’s disease, Crohn’s disease, autism, multiple sclerosis, epilepsy, and chronic pain. These findings are summarized in the “Medical Cannabis Research Synopsis” (here), a vital resource for medical professionals.

Today, Tikun Olam operates globally with state-of-the-art cultivation facilities in the USA, Canada, Israel, and Greece.

Facilities of Tikun Olam Europe in Greece
Science-based insights into medical cannabis
Explore the scientific diversity of the TIKUN Research Synopsis
The plant in Greece

High-tech Cultivation in the Heart of Greece

The state-of-the-art Tikun Olam Europe facility in Greece was launched in 2022 and is among the most advanced in the world. Covering 56,000 m², it is one of the largest production units in Europe. Tikun Olam Europe was the first company in Greece to be licensed by the National Organization for Medicines (EOF). The facility is EU-GMP and GACP certified, ensuring the highest standards for the production and processing of medical cannabis. Since its establishment in 2018, Tikun Olam Europe has been setting new benchmarks in quality and innovation.

56,000 m² of Modern Production Space

Setting a new benchmark in cannabis production with GACP and EU-GMP certifications.

Innovation for Commercial Solutions

Advanced systems and uncompromising quality standards for the international cannabis and pharmaceutical markets.

Sustainability Meets Precision

Environmentally friendly production utilizing advanced technologies for efficiency and independence.

Cannabis from Greece

Quality Backed by Regulatory Guarantees

Medical cannabis has been legal in Greece since 2017. However, strict regulations require that all medical cannabis products be officially registered and licensed by Greek authorities before they can be made available in any market. This process includes the submission of a detailed quality dossier, ensuring that only the highest-quality products meet the required standards. As a result, Greek medical cannabis undergoes an additional layer of licensing, quality assurance, making it a trusted and premium choice for the international market.

For more information available exclusively to professionals, please log in to access additional resources.

These strict requirements include the submission and approval of a detailed quality dossier, which gives cannabis from Greece an additional and unique quality guarantee. This makes Greek products a reliable and first-class choice for the international market.

We may only provide the following information to professionals.
Please log in to do so: